DMII
Drugs Made In America Acquisition II Corp. Ordinary SharesNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$637.64M
P/E Ratio
66.73
EPS
$0.15
Beta
—
52W High
$10.01
52W Low
$9.86
50-Day MA
$9.98
200-Day MA
$9.95
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on merging with innovative firms within the pharmaceuticals and biotechnology sectors to enhance domestic drug manufacturing capabilities. Leveraging the extensive expertise of its management team, DMII identifies and executes strategic transactions that align with rising market demands and prioritize sustainable practices. Through its commitment to fostering resilient supply chains and advancing U.S. healthcare self-sufficiency, DMII aims to deliver sustained value for its shareholders and contribute to the long-term growth of the American pharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -812,113 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.32% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.26 |
| Price-to-Book | 1.31 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $63.70M |
| Float | $50.64M |
| % Insiders | 18.16% |
| % Institutions | 55.98% |
Historical Volatility
HV 10-Day
1.19%
HV 20-Day
1.46%
HV 30-Day
1.46%
HV 60-Day
2.03%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/25/2026